Day Zero Diagnostics Wins $6.2M From Accelerator
May 12 2020
CARB-X award to fund DZD’s new technology to rapidly identify pathogens and determine their drug resistance profile
Read More
DZD Using CARB-X Award to Commercialize Antibiotic-Resistance Testing Platform
May 11 2020
360Dx reporter John Gilmore covers DZD’s plans to advance new diagnostic system with CARB-X funding
Read More
CARB-X Awards DZD $6.2M to Develop New Test To Diagnose Deadly Superbug Infections
May 11 2020
Funding award is the first whole genome sequencing and machine learning technology in CARB-X portfolio
Read More
New Genomic Tests Aim to Diagnose Deadly Infections Faster
February 24 2020
DZD included in the new class of diagnostics for infectious diseases
Read More
Diagnostic Startups Take on Growing Threat of Antibiotic-Resistant Bugs
January 14 2020
DZD featured in WSJ review of emerging diagnostic companies
Read More
Genomics Links Fecal Transplant Recipient Infections to Drug-Resistant E. coli Donor
October 31 2019
EpiXact uses sequencing to confirm cause of patient death in a clinical trial with wide ranging implications
Read More